COVID-19 Statement

In light of the global spread of COVID-19, which has affected us all, FIDE is refocusing its priorities and will join the efforts of other organizations to do everything possible to prevent the spread of this disease, and ensure the health and wellbeing of its team members, colleagues, and the general population. In the short term, all our team are working remotely and will be unable to provide you with the usual face-to-face opportunities. However, we remain committed to doing everything we can to support our clients and ensure improved outcomes for patients. To this end, we are offering virtual training and consulting solutions that can help you adapt to evolving market scenarios.

Let’s talk

Expedited Expert Engagement: Rapid access to clinical insight, direct from experts, to meet your time-sensitive needs

Throughout a product’s life cycle, from early-stage development to post-launch, pharmaceutical and biotechnology companies often need answers to critical questions quickly. To complement and enhance traditional expert engagements, FIDE’s Expedited Expert Engagement enables industry to gain high-level insights from multiple experts in a short time frame.

This is what we do

Access to a global
network of experts

Access to a global network of experts providing evidence-based and pragmatic perspectives from academia and community practice, with specific regional expertise


Agile platform that facilitates consults at 2 weeks’* notice from initial request

Rapid responses to
critical questions

Rapid responses to critical questions to expedite development of medical or commercial strategy


Subscription service: No need to prepare separate contracts for each individual engagement

Ready to begin?

Start booking your forum today

Find out more

Request a callback:

Email successfully sent

We'll try to call you back as soon as possible, thank you for taking the time to contact us.